CIK: 0002006045
Total reported value
$52.8M
Reporting period: 2026-03-31 · Number of holdings: 6
SymBiosis Capital Partners, LLC disclosed 6 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $52.8M and a quarterly turnover rate of 100.0%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "S"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add EVMN
0.0% $7.5M
Add IVA
-9.5% $974.7K
Trim RANI
-41.8% -$5.8M
Trim CLNN
-44.0% -$2.4M
Sold out VSTM
Sold out AMPG
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | EVMN | Evommune INC | Stock-Other | 55.80% | +35.77% | — | |
| 2 | IVA | Inventiva SA - Adr | Stock-Other | 24.76% | +13.72% | -9.46% | |
| 3 | WVE | Wave Life Sciences Ltd. | Stock-Other | 10.30% | +10.30% | NEW | |
| 4 | RANI | Rani Therapeutics Holdings-a | Stock-Other | 5.11% | -2.66% | -41.78% | |
| 5 | CLNN | Clene INC | Stock-Other | 4.03% | -0.10% | -44.05% | |
| 6 | SRZNW | Surrozen Inc-cw25 | Stock-Other | — | — | — |
Performance for Q3 2026
-28.9%
Performance Last 4 Quarters
-39.1%
Based on 5 months of available history
Not enough sector-mapped data yet
SymBiosis Capital Partners, LLC's most significant position changes for 2026-03-31: Sold out: Verastem INC (VSTM); Sold out: Amplitech Group INC (AMPG); Sold out: Precigen INC (PGEN); Sold out: Nuvation Bio INC (NUVB); Sold out: Aardvark Therapeutics INC (AARD).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | EVMN | Evommune INC | +35.8% | — | Unchanged |
| 2 | IVA | Inventiva SA - Adr | +13.7% | -9.46% | Trim |
| 3 | SRZNW | Surrozen Inc-cw25 | — | — | Unchanged |
| 4 | CLNN | Clene INC | -0.1% | -44.05% | Trim |
| 5 | RANI | Rani Therapeutics Holdings-a | -2.7% | -41.78% | Trim |
| 6 | VSTM | Verastem INC | — | EXIT | Sold out |
| 7 | AMPG | Amplitech Group INC | — | EXIT | Sold out |
| 8 | PGEN | Precigen INC | — | EXIT | Sold out |
| 9 | NUVB | Nuvation Bio INC | — | EXIT | Sold out |
| 10 | AARD | Aardvark Therapeutics INC | — | EXIT | Sold out |
| 11 | WVE | Wave Life Sciences Ltd. | — | NEW | New buy |
| 12 | ✓ | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-12 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-12 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002046144
Total reported value
$52.8M
1 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001557787
Total reported value
$52.7M
88 stks
2023-12-31
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001719814
Total reported value
$52.7M
108 stks
2020-03-31
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001757283
Total reported value
$176.9M
7 stks
2026-03-31
2 of the top 5 holdings overlap, including Evommune INC
CIK 0001131399
Total reported value
$599.2M
13 stks
2026-03-31
1 of the top 5 holdings overlap, including Wave Life Sciences Ltd.
CIK 0001274413
Total reported value
$120.7M
77 stks
2026-03-31
1 of the top 5 holdings overlap, including Evommune INC